Develops, manufactures and distributes vaccines and other pharmaceutical products
GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.
It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.
The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.
The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.
The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.
The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Shareholders GlaxoSmithKline plc (GSK - London Stock Exchange) GlaxoSmithKline plc (GSK - Nyse)
Name Shares % BlackRock Investment Management (UK) Ltd. 199,772,316
4.11% Legal & General Investment Management Ltd. 149,809,659
3.08% Norges Bank Investment Management 98,481,000
2.02% The Vanguard Group, Inc. 89,390,003
1.84% Aberdeen Asset Investments Ltd. 78,474,848
1.61% State Administration of Foreign Exchange (Invt Mgmt) 64,586,084
1.33% State Street Global Advisors Ltd. 63,384,556
1.30% Capital Research & Management Co. (Global Investors) 60,768,000
1.25% Schroder Investment Management Ltd. 60,331,119
1.24% Threadneedle Asset Management Ltd. 57,226,792
Name Shares % Valuation
Aspen Pharmacare Holdings Limited (APNJ) 28,370,780 6.22% 858,990,901 USD GlaxoSmithKline Pakistan Ltd. 263,010,098 82.6% 481,766,117 USD Theravance Biopharma Inc (TBPH) 8,299,218 24.5% 132,787,488 USD GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 444,065,541 46.4% 122,730,834 USD GlaxoSmithKline S.A.E. 76,161,378 91.2% 111,296,907 USD Dong-A Socio Holdings Co Ltd (000640) 409,693 9.05% 58,664,064 USD GALAPAGOS (GLPG) 508,644 1.65% 21,413,434 USD Allergy Therapeutics plc (AGY) 10,118,000 1.85% 3,420,795 USD Response Genetics, Inc. (RGDX) 5,000,000 12.9% 1,500,000 USD Serendex Pharmaceuticals A/S (SENDEX) 98,010 0.65% 91,045 USD
GlaxoSmithKline plc : Connections
Rockefeller Family Trust, Inc.
Royal Bank of Scotland Plc
European Federation of Pharmaceutical Industries & Assns
Business Council for Britain
National Academy of Sciences
Singapore Economic Development Board
The Council for Industry & Higher Education
The Natural History Museum
National Theatre of Scotland
Harvey Nichols Group Ltd.
Biotechnology Industry Organization
The University of Texas Southwestern Medical Center
The University of Nottingham
Carnegie Hall Society, Inc.
Longwood Fund Management LLC
Lincoln Center for the Performing Arts, Inc.
Southwestern Medical Foundation
NYU Langone Medical Center
The Trilateral Commission
French Academy of Sciences
Federal Reserve Bank of New York
Pharmaceutical Research & Manufacturers of America
Napp Pharmaceutical Holdings Ltd.
American Academy of Arts & Sciences
Genelabs Technologies, Inc.
United Kingdom Department for Business Innovation & Skills
Mundipharma International Ltd.
American Chemical Society
Massachusetts Institute of Technology
Company contact information 980 Great West road TW8 9GS Brentford, Greater London United Kingdom Phone : +44 (0)20 8047 5000 Fax : +44 (0)20 8047 7807 Internet : http://www.gsk.com
- London Stock Exchange, SETS
- Main Market
- Stoxx Europe 50 / FTSE 100, FTSE Eurotop 100, Stoxx Global 200, Stoxx UK 50
- ISIN Code :
- Bloomberg Code :
- Reuters Code :
- Datastream Code :
© 2015 People , Fundamentals and Ownership
© 2015 Cofisem